Clinical versus statistical significance

Clinical significance vs. statistical significance

In Randomized Controlled Trials (RCTs), interpreting results requires understanding both statistical significance and clinical significance. While they are related, they address different questions: one about the likelihood of an effect being real, and the other about whether that effect matters in practice.

1. Statistical Significance

Definition: Statistical significance tests whether an observed effect is likely due to chance.

Key Features

• Determined using p-values and confidence intervals (CIs).
• A p-value < 0.05 is commonly used to denote significance, implying a less than 5% probability that the effect occurred by chance.
• Confidence intervals provide a range of plausible values for the effect; if the CI excludes the null (e.g., 0 for mean difference, 1 for risk ratio), the result is statistically significant.

Example:

A new drug reduces systolic blood pressure by 5 mmHg compared to placebo (p = 0.03, 95% CI: 1.2–8.8). → Interpretation: The result is statistically significant since p < 0.05 and the CI does not include 0.

Limitations

• Does not indicate whether the result is clinically meaningful.
• Strongly influenced by sample size—small effects can appear statistically significant in large trials and vice versa.

2. Clinical Significance

Definition: Clinical significance assesses whether an effect is meaningful and beneficial in real-world patient care.

Key Features

• Focuses on effect size and relevance to patient outcomes, not just p-values.
• Often judged using the Minimal Clinically Important Difference (MCID), the smallest difference patients or clinicians consider beneficial.
• MCID is based on previous literature, expert consensus, or patient-reported outcomes.

Example:

A new drug reduces systolic blood pressure by 5 mmHg, but the MCID is 10 mmHg. → Interpretation: The effect is statistically significant but not clinically significant.

Limitations

• Involves clinical judgment and may vary by setting, population, or outcome.
• No universally accepted thresholds for all outcomes.

3. Comparing Statistical vs. Clinical Significance

Comparison of Statistical and Clinical Significance

Aspect	Statistical Significance	Clinical Significance
Definition	Likelihood that an effect is not due to chance	Whether the effect is meaningful for patients
Measure	p-value, confidence interval	Minimal Clinically Important Difference (MCID)
Depends on	Sample size, variability	Patient outcomes, clinical judgment
Limitations	May detect small, unimportant differences	Can be subjective, lacks universal thresholds
Example	p = 0.02 for a 2 mmHg BP reduction	A 10 mmHg reduction is considered clinically important

4. Best Practices in RCTs

• Report both statistical and clinical significance for a complete interpretation.
• Consider effect size measures (e.g., Cohen’s d, risk difference, odds ratio).
• Present confidence intervals to show precision and plausible ranges.
• Predefine the MCID in protocols and analysis plans.

Conclusion

• Statistical significance does not imply clinical importance.
• RCTs should prioritize outcomes that are meaningful for patients, not just statistically detectable.
• Reporting and interpreting both types of significance supports better decision-making in clinical and policy settings.

Bibliography

1. Feinstein AR. The unit of analysis in epidemiology: the fallacy of comparing groups when individuals are the goal. American Journal of Epidemiology. 1985;121(1):1–8.
2. Guyatt GH, Jaeschke R, Heddle N, et al. Basic statistics for clinicians: 2. Interpreting study results: confidence intervals. CMAJ. 1995;152(2):169–173.
3. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Controlled Clinical Trials. 1989;10(4 Suppl):407S–415S.
4. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston: Little, Brown and Company; 1991. Chapter 5: Statistical versus clinical significance.
5. Goodman SN. Toward evidence-based medical statistics. 2: The Bayes factor. Annals of Internal Medicine. 1999;130(12):1005–1013.

---

Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.